南華集團控股(00413.HK)2024年總收入32.32億港元 同比增加約12%
格隆匯3月18日丨南華集團控股(00413.HK)公吿,截至2024年12月31日止年度,集團錄得總收入32.32億港元,相比2023年增加約12%,而年度除税後溢利為1200萬港元,2023年則錄得除税後虧損4200萬港元。年度公司擁有人應占每股基本盈利約為0.01港仙(2023年:每股虧損:0.25港仙)。
財務業績轉虧為盈,歸因於(i)玩具產品消費需求回升帶動貿易及製造業務經營業績改善;(ii)平均利率下降致使財務成本下降;(iii)年度已確認出售附屬公司收益較2023年有所增加。集團整體財務、業務及貿易狀況維持穩健。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.